Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) Return on Assets (2020 - 2025)

Foghorn Therapeutics has reported Return on Assets over the past 6 years, most recently at 0.39% for Q4 2025.

  • Quarterly results put Return on Assets at 0.39% for Q4 2025, down 9.0% from a year ago — trailing twelve months through Dec 2025 was 0.39% (down 9.0% YoY), and the annual figure for FY2025 was 0.32%, down 2.0%.
  • Return on Assets for Q4 2025 was 0.39% at Foghorn Therapeutics, down from 0.35% in the prior quarter.
  • Over the last five years, Return on Assets for FHTX hit a ceiling of 0.21% in Q1 2022 and a floor of 0.48% in Q3 2021.
  • Median Return on Assets over the past 5 years was 0.31% (2023), compared with a mean of 0.31%.
  • Biggest five-year swings in Return on Assets: rose 24bps in 2022 and later dropped -9bps in 2023.
  • Foghorn Therapeutics' Return on Assets stood at 0.29% in 2021, then grew by 11bps to 0.26% in 2022, then fell by -27bps to 0.33% in 2023, then increased by 11bps to 0.29% in 2024, then crashed by -32bps to 0.39% in 2025.
  • The last three reported values for Return on Assets were 0.39% (Q4 2025), 0.35% (Q3 2025), and 0.32% (Q2 2025) per Business Quant data.